Comparison between the Effects of Bretschneider’s HTK Solution and Cold Blood Cardioplegia on Systemic Endothelial Functions in Patients who Undergo Coronary Artery Bypass Surgery: a Prospective Randomized and Controlled Trial

Comparison between the Effects of Bretschneider’s HTK Solution and Cold Blood Cardioplegia on Systemic Endothelial Functions in Patients who Undergo Coronary Artery Bypass Surgery: a Prospective Randomized and Controlled Trial

Abstract Objective: To investigate the effects of Bretschneider’s histidine-tryptophan-ketoglutarate (HTK) solution and cold blood cardioplegia on systemic endothelial functions. Methods: A total of 50 patients who underwent isolated coronary artery bypass surgery between March 2018 and May 2018...

Full description

Bibliographic Details
Main Authors:	Ilker Mercan, Yuksel Dereli, Cemile Topcu, Omer Tanyeli, Mehmet Isik, Niyazi Gormus, Elifnur Yildirim Ozturk
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Cirurgia Cardiovascular 2020-05-01
Series:	Brazilian Journal of Cardiovascular Surgery
Subjects:	Bretschneider cardioplegic solution. Von Willebrand Factor. Histidine. Heart Arrest Induced. Potassium Chloride. Coronary Artery Bypass
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382020000500008&tlng=en

Similar Items

Del Nido versus Bretschneider cardioplegic solution in valve replacement for severe aortic stenosis – a case-control pilot study
by: Krzysztof Sanetra, et al.
Published: (2022-06-01)

Acute hyponatremia after cardioplegia by histidine-tryptophane-ketoglutarate – a retrospective study
by: Lindner Gregor, et al.
Published: (2012-06-01)

Comparison of del Nido Cardioplegia vs. blood cardioplegia in adult aortic surgery: Is the single-dose cardioplegia technique really advantageous?
by: Cuneyt Eris, et al.
Published: (2022-05-01)

The Molecular Genetics of von Willebrand Disease
by: Ergül Berber
Published: (2012-12-01)

Custodial Cardioplegia and Cardiac Preservation during pediatric Cardiac Surgery Procedures: A Narrative Review
by: Javad Ramezani, et al.
Published: (2019-03-01)

Enfermedad de von Willebrand adquirida. Aspectos generales Acquired von Willebrand’s disease. General aspects
by: Alina Díaz Concepción
Published: (2004-04-01)

Surgical results of only antegrade del Nido cardioplegia infusion in conventional coronary artery bypass grafting: a retrospective study
by: Sang-Uk Park, et al.
Published: (2023-11-01)

Del Nido cardioplegia versus other contemporary solutions for myocardial protection – a literature review
by: Barbara Brzeska, et al.
Published: (2023-06-01)

Von Willebrand Factor Multimeric Assay in Acquired von Willebrand Disease Diagnosis: A Report of Experience from North Estonia Medical Centre
by: Marika Pikta, et al.
Published: (2021-06-01)

Comparison of del Nido Cardioplegia with Blood Cardioplegia in Coronary Artery Bypass Grafting Combined with Mitral Valve Replacement
by: Ali Aycan Kavala, et al.

Patient with von Willebrand Disease for Gynaecologic Surgery - Perianaesthetic Concerns
by: Rakesh Garg, et al.
Published: (2008-01-01)

Multiple Sclerosis Diagnosed in a Woman With Von-Willebrand Disease: A Case Report
by: Mohsen Farjoud Kouhanjani, et al.
Published: (2022-07-01)

Single-Dose Del Nido Cardioplegia vs. Blood Cardioplegia in Aortic Valve Replacement Surgery
by: Haci Ali Ucak, et al.
Published: (2020-12-01)

Comparison of Del Nido Cardioplegia and Blood Cardioplegia in Terms of Development of Postoperative Atrial Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass Grafting
by: Umut Serhat Sanrı, et al.
Published: (2020-09-01)

Von Willebrand disease : basic and clinical aspects /
by: Federici, Augusto B. 534507
Published: (c201)

Analysis of von Willebrand Disease in the “Heart of Europe”
by: Inge Vangenechten, et al.
Published: (2022-10-01)

Polymorphism in the promoter region of von Willebrand factor gene and von Willebrand disease type 1
by: Daniel Simon, et al.
Published: (2003-12-01)

von Willebrand Disease: The diagnosis and management of this bleeding disorder
by: Basim A. Abd, et al.
Published: (2020-01-01)

Hyperkalemic or Low Potassium Cardioplegia Protects against Reduction of Energy Metabolism by Oxidative Stress
by: Hongting Diao, et al.
Published: (2023-02-01)

Genetic Alterations, DNA Methylation, Alloantibodies and Phenotypic Heterogeneity in Type III von Willebrand Disease
by: Muhammad Asif Naveed, et al.
Published: (2022-05-01)

Desmopressin testing in von Willebrand disease: Lowering the burden
by: Jessica M. Heijdra, et al.
Published: (2022-08-01)

Von Willebrand hastalığı’nda oral cerrahi yaklaşım: olgu sunumu
by: Ahmet Arslan, et al.
Published: (2011-11-01)

Diagnosis of von Willebrand disease during the management of deep neck abscess: A case report
by: Akihisa Tanaka, et al.
Published: (2022-12-01)

Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients
by: Eric Manderstedt, et al.
Published: (2018-01-01)

[Cost-minimization analysis of replacement therapy in the treatment of von Willebrand disease]
by: Giancarlo Castaman
Published: (2016-06-01)

Maltrato infantil, como forma de debut de hemofilia A: presentación de un caso Child abuse, as a form of hemophilia A: presentation of a case
by: Ricardo Busto Aguiar, et al.
Published: (2011-12-01)

Common and Rare Variants in Genes Associated with von Willebrand Factor Level Variation: No Accumulation of Rare Variants in Swedish von Willebrand Disease Patients
by: Eric Manderstedt, et al.
Published: (2020-10-01)

Von Willebrand Disease in the elderly: clinical perspectives
by: Chapin J
Published: (2018-08-01)

Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer—Single-Center Experience
by: Ingrid Skornova, et al.
Published: (2021-11-01)

Acquired von Willebrand disease: from theory to practice. A single center experience - three case reports
by: Colită Andrei, et al.
Published: (2016-03-01)

VON WILLEBRAND DISEASE
by: Valeriu Popescu, et al.
Published: (2009-11-01)

Polyphosphate Activates von Willebrand Factor Interaction with Glycoprotein Ib in the Absence of Factor VIII In Vitro
by: Marcela Montilla, et al.
Published: (2022-11-01)

Establishing reference intervals for von Willebrand factor multimers
by: Pikta Marika, et al.
Published: (2022-01-01)

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease
by: Gritsch H, et al.
Published: (2022-11-01)

Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand Disease
by: Michelle Sholzberg, et al.
Published: (2021-07-01)

vWDI is inherited in an autosomal dominant manner with incomplete penetrance, in the Kromfohrländer breed
by: Julia H. Segert, et al.
Published: (2019-05-01)

Evaluation of the modified HTK solution in pancreas transplantation—An experimental model
by: Majid Esmaeilzadeh, et al.
Published: (2016-04-01)

Profil du facteur Von Willebrand dans la grossesse: étude descriptive chez 390 femmes enceintes au Maroc
by: Mamad Hassane, et al.
Published: (2018-12-01)

Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow
by: Hiroaki Yaoi, et al.
Published: (2023-12-01)

Allopurinol-induced acquired von Willebrand syndrome
by: Juan Eirís, et al.
Published: (2023-10-01)